|
1
|
Lian JH, Wang WH, Wang JQ, Zhang YH and Li
Y: MicroRNA-122 promotes proliferation, invasion and migration of
renal cell carcinoma cells through the PI3K/Akt signaling pathway.
Asian Pac J Cancer Prev. 14:5017–5021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toma MI, Erdmann K, Diezel M, Meinhardt M,
Zastrow S, Fuessel S, Wirth MP and Baretton GB: Lack of ephrin
receptor A1 is a favorable independent prognostic factor in clear
cell renal cell carcinoma. PloS One. 9:e1022622014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang YQ and Chen J: Predictive role of
vascular endothelial growth factor polymorphisms in the survival of
renal cell carcinoma patients. Genet Mol Res. 13:5011–5017. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kardas I, Mrózek K, Babinska M, Krajka K,
Hadaczek P, Lubinski J, Roszkiewicz A, Kuziemska E and Limon J:
Cytogenetic and molecular findings in 75 clear cell renal cell
carcinomas. Oncol Rep. 13:949–956. 2005.PubMed/NCBI
|
|
6
|
Girolami F, Passerini I, Gargano D,
Frusconi S, Villari D, Nicita G and Torricelli F: Microsatellite
analysis of chromosome 3p region in sporadic renal cell carcinomas.
Pathol Oncol Res. 8:241–244. 2002. View Article : Google Scholar
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu D, Tao J, Xu B, Li P, Lu Q and Zhang W:
Downregulation of Dicer, a component of the microRNA machinery, in
bladder cancer. Mol Med Rep. 5:695–699. 2012.
|
|
9
|
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee
JK, Sohn SY, Cho Y, Zhang BT and Kim VN: Molecular basis for the
recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell.
125:887–901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee Y, Han J, Yeom KH, Jin H and Kim VN:
Drosha in primary microRNA processing. Cold Spring Harb Symp Quant
Biol. 71:51–57. 2006. View Article : Google Scholar
|
|
12
|
Yeom KH, Lee Y, Han J, Suh MR and Kim VN:
Characterization of DGCR8/Pasha, the essential cofactor for Drosha
in primary miRNA processing. Nucleic Acids Res. 34:4622–4629. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bohnsack MT, Czaplinski K and Gorlich D:
Exportin 5 is a RanGTP-dependent dsRNA-binding protein that
mediates nuclear export of pre-miRNAs. RNA. 10:185–191. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chendrimada TP, Gregory RI, Kumaraswamy E,
Norman J, Cooch N, Nishikura K and Shiekhattar R: TRBP recruits the
Dicer complex to Ago2 for microRNA processing and gene silencing.
Nature. 436:740–744. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lund E, Guttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar
|
|
16
|
Berdnik D, Fan AP, Potter CJ and Luo L:
MicroRNA processing pathway regulates olfactory neuron
morphogenesis. Curr Biol. 18:1754–1759. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu W, Pang L, Chen Y, Yang L, Zhu J and
Wei Y: The microRNAs as prognostic biomarkers for survival in
esophageal cancer: A meta-analysis. Scientific World Journal.
2014:5239792014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yuan W, Sui C, Liu Q, Tang W, An H and Ma
J: Up-regulation of microRNA-145 associates with lymph node
metastasis in colorectal cancer. PloS One. 9:e1020172014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Li L, Su J and Zhang G: Decreased
miR-204 in H. pylori-associated gastric cancer promotes cancer cell
proliferation and invasion by targeting SOX4. PloS One.
9:e1014572014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:D152–D157. 2011. View Article : Google Scholar :
|
|
23
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar :
|
|
24
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar :
|
|
25
|
Zhou Y, Wu D, Tao J, Qu P, Zhou Z and Hou
J: MicroRNA-133 inhibits cell proliferation, migration and invasion
by targeting epidermal growth factor receptor and its downstream
effector proteins in bladder cancer. Scand J Urol. 47:423–432.
2013. View Article : Google Scholar
|
|
26
|
Xue YJ, Xiao RH, Long DZ, Zou XF, Wang XN,
Zhang GX, Yuan YH, Wu GQ, Yang J, Wu YT, et al: Overexpression of
FoxM1 is associated with tumor progression in patients with clear
cell renal cell carcinoma. J Transl Med. 10:2002012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bauer VL, Braselmann H, Henke M, Mattern
D, Walch A, Unger K, Baudis M, Lassmann S, Huber R, Wienberg J, et
al: Chromosomal changes characterize head and neck cancer with poor
prognosis. J Mol Med (Berl). 86:1353–1365. 2008. View Article : Google Scholar
|
|
28
|
Abou-Elhamd KE, Habib TN, Moussa AE and
Badawy BS: The role of genetic susceptibility in head and neck
squamous cell carcinoma. Eur Arch Otorhinolaryngol. 265:217–222.
2008. View Article : Google Scholar
|
|
29
|
Scully C, Field JK and Tanzawa H: Genetic
aberrations in oral or head and neck squamous cell carcinoma 2:
Chromosomal aberrations. Oral Oncol. 36:311–327. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lagos-Quintana M, Rauhut R, Meyer J,
Borkhardt A and Tuschl T: New microRNAs from mouse and human. RNA.
9:175–179. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang FE, Zhang C, Maminishkis A, Dong L,
Zhi C, Li R, Zhao J, Majerciak V, Gaur AB, Chen S and Miller SS:
MicroRNA-204/211 alters epithelial physiology. FASEB J.
24:1552–1571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong M, Ma J, Li M, Zhou M, Hock JM and Yu
X: MicroRNA-204 critically regulates carcinogenesis in malignant
peripheral nerve sheath tumors. Neuro Oncol. 14:1007–1017. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Garzon R, Garofalo M, Martelli MP,
Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG,
Schnittger S, Haferlach T, et al: Distinctive microRNA signature of
acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Proc Natl Acad Sci USA. 105:3945–3950. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mikhaylova O, Stratton Y, Hall D, Kellner
E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J and
Czyzyk-Krzeska MF: VHL-regulated MiR-204 suppresses tumor growth
through inhibition of LC3B-mediated autophagy in renal clear cell
carcinoma. Cancer cell. 21:532–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Huang J, Zhao L, Xing L and Chen D:
MicroRNA-204 regulates Runx2 protein expression and mesenchymal
progenitor cell differentiation. Stem cells. 28:357–364. 2010.
|
|
36
|
Courboulin A, Paulin R, Giguère NJ,
Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher
S, Côté J, et al: Role for miR-204 in human pulmonary arterial
hypertension. J Exp Med. 208:535–548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Conte I, Carrella S, Avellino R, Karali M,
Marco-Ferreres R, Bovolenta P and Banfi S: miR-204 is required for
lens and retinal development via Meis2 targeting. Proc Natl Acad
Sci USA. 107:15491–15496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Natera-Naranjo O, Aschrafi A, Gioio AE and
Kaplan BB: Identification and quantitative analyses of microRNAs
located in the distal axons of sympathetic neurons. RNA.
16:1516–1529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu
Y, Li J, Hasina R, Cheng C, Lingen MW, et al: Network modeling
identifies molecular functions targeted by miR-204 to suppress head
and neck tumor metastasis. PLoS Comput Biol. 6:e10007302010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chung TK, Lau TS, Cheung TH, Yim SF, Lo
KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, et al: Dysregulation
of microRNA-204 mediates migration and invasion of endometrial
cancer by regulating FOXC1. Int J Cancer. 130:1036–1045. 2012.
View Article : Google Scholar
|
|
41
|
Ryan J, Tivnan A, Fay J, Bryan K, Meehan
M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, et al:
MicroRNA-204 increases sensitivity of neuroblastoma cells to
cisplatin and is associated with a favourable clinical outcome. Br
J Cancer. 107:967–976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar :
|
|
43
|
Penzo-Mendez AI: Critical roles for SoxC
transcription factors in development and cancer. Int J Biochem Cell
Biol. 42:425–428. 2010. View Article : Google Scholar :
|
|
44
|
Gunes S, Yegin Z, Sullu Y, Buyukalpelli R
and Bagci H: SOX4 expression levels in urothelial bladder
carcinoma. Pathol Res Pract. 207:423–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hur W, Rhim H, Jung CK, Kim JD, Bae SH,
Jang JW, Yang JM, Oh ST, Kim DG, Wang HJ, et al: SOX4
overexpression regulates the p53-mediated apoptosis in
hepatocellular carcinoma: Clinical implication and functional
analysis in vitro. Carcinogenesis. 31:1298–1307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aaboe M, Birkenkamp-Demtroder K, Wiuf C,
Sørensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjøt L and
Ørntoft T: SOX4 expression in bladder carcinoma: Clinical aspects
and in vitro functional characterization. Cancer Res. 66:3434–3442.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jang SM, Kang EJ, Kim JW, Kim CH, An JH
and Choi KH: Transcription factor Sox4 is required for
PUMA-mediated apoptosis induced by histone deacetylase inhibitor,
TSA. Biochem Biophys Res Commun. 438:445–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jafarnejad SM, Wani AA, Martinka M and Li
G: Prognostic significance of Sox4 expression in human cutaneous
melanoma and its role in cell migration and invasion. Am J Pathol.
177:2741–2752. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liao YL, Sun YM, Chau GY, Chau YP, Lai TC,
Wang JL, Horng JT, Hsiao M and Tsou AP: Identification of SOX4
target genes using phylogenetic footprinting-based prediction from
expression microarrays suggests that overexpression of SOX4
potentiates metastasis in hepatocellular carcinoma. Oncogene.
27:5578–5589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pramoonjago P, Baras AS and Moskaluk CA:
Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3
cells. Oncogene. 25:5626–5639. 2006. View Article : Google Scholar : PubMed/NCBI
|
